-

COVID-19 Economic Impact Report on the Global Fiber Cement Industry - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "COVID-19 Economic Impact Report: Global Fiber Cement" report has been added to ResearchAndMarkets.com's offering.

The global fiber cement industry is facing a number of challenges as it deals with the impact of the COVID-19 pandemic. How has the macroeconomic environment changed and what does it mean for the global fiber cement industry going forward?

The "COVID-19 Economic Impact Report: Global Fiber Cement" report looks at how the expected impact of the pandemic on the current macroeconomic environment compares to other major events since 2000, including the bursting of technology bubble, the SARS outbreak, the 2009 global downturn, and the European financial crisis. It also provides a historical view of global industry sales since 2000, a look at how the industry is being currently impacted, and estimates for global industry sales through 2023.

Fiber cement applications include:

  • roofing
  • siding (cladding)
  • backerboard
  • moulding and trim
  • other applications (ceilings, countertops, firestop materials, interior wall panels, pipe, porch ceilings, and sound suppression boards)

Key Topics Covered:

  • Introduction
  • Macroeconomic Overview
  • Number of Covid-19 Cases in the US
  • Fiber Cement Market: Historical Perspective
  • Covid-19 Pandemic vs Recent Recessions
  • Fiber Cement Market: Covid-19 Impact
  • Additional Information

For more information about this report visit https://www.researchandmarkets.com/r/i7m15l

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Blockchain and Non-Fungible Tokens new Technologies and the Relevant Law Training Course: Core Principles, Smart Contracts, NFTs, and Decentralized Finance Explained (Online Event: May 20, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Blockchain and Non-Fungible Tokens: Understanding new Technologies and the Relevant Law Training Course (May 20, 2026)" training has been added to ResearchAndMarkets.com's offering. Blockchain is a new technology that could potentially have major impacts in a wide range of industries. It has the potential to dramatically change how business is conducted - but there is no one central authority controlling blockchain, everyone has access to the same information. Are...

Writing Clinical Research with Integrity Training Course: Principles of Medical and Scientific Writing, Including Ethical Standards, Data Integrity, and Plagiarism Prevention (Online: Apr 20, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Writing Clinical Research with Integrity Training Course (Apr 20, 2026)" training has been added to ResearchAndMarkets.com's offering. This course covers key principles of medical and scientific writing, including ethical standards, data integrity, and plagiarism prevention. Participants will learn how to tailor content for various audiences, structure documents (e.g., manuscripts, protocols), and adhere to writing standards such as clarity, consistency, and correc...

In-Vitro Diagnostic Regulation (EU) 2017/746 Introduction Training Course (Online Event: Apr 16th - Apr 17th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Introduction to the In-Vitro Diagnostic Regulation (IVDR) Training Course (Apr 16th - Apr 17th, 2026)" training has been added to ResearchAndMarkets.com's offering. The In-Vitro Diagnostic Regulation (EU) 2017/746, which came into force in May 2017 with a transition period of five years, is intended to strengthen the current approval system for in-vitro diagnostics and makes substantial changes to the existing IVD Directive (98/79/EC) legislation. The Regulation in...
Back to Newsroom